Herbert Loong, Clinical Associate Professor at The Chinese University of Hong Kong, and Steering Committee Member at Lung Cancer Policy Network, shared a post by APODDC on LinkedIn, adding:
“Join us for the 2nd APODDC Page vMTB next week!
We will be focusing on how best to integrate molecular data into treatment planning, and also taking a deeper dive into specifics in prostate and bladder cancers as examples of how a Molecular Tumour Board can be beneficial.
Registration is free! Come join us next Wednesday afternoon HKT/SGT!”
Quoting APODDC‘s post:
“It is 10 days to the 2nd APODDC vMTB!
We’re excited to have our second session hosted by our executive member Prof Toshio Shimizu. We will be joined by Dr Tahlia Scheinberg and A/Prof Ben Tran, where the speakers will discuss the profiling strategies used within the field of bladder and prostate cancer using case studies, and touch on treatment planning.
Do remember to register if you have yet to, and we look forward to hosting you at the session.”
More posts featuring Herbert Loong on OncoDaily.